Optimizing Adherence to Antiretroviral Therapy

  • Author: Nancy Reynolds, PhD, RN, C-NP, FAAN (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 3/21/18 (What's New)


AIDS Education and Training Centers National Resource Center. Available at: http://www.aidsetc.org/. Accessed March 21, 2018.[AETC]

Ahlenstiel G, Roomp K, Däumer M, et al. Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level. Clin Vaccine Immunol. 2007;14:1266-1273.[Ahlenstiel 2007]

Airoldi M, Zaccarelli M, Bisi L, et al. One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence. 2010;4:115-125.[Airoldi 2010]

Amico KR, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. J Acquir Immune Defic Syndr. 2006;41:285-297.[Amico 2006]


Action required

Keywords: Adherence